Paul J. Bröckelmann
University of Cologne(DE)Düsseldorf University Hospital(DE)University Hospital Cologne(DE)Max Planck Institute for Biology of Ageing(DE)Heinrich Heine University Düsseldorf(DE)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, CNS Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma(2020)163 cited
- → PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial(2021)156 cited
- → Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials(2017)138 cited
- → Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials(2016)112 cited
- → The emerging role of immune checkpoint inhibition in malignant lymphoma(2016)111 cited
- → Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma(2017)